Dysfunction of the CP-CSF-axis is thought to contribute to the build-up of toxic proteins that are one of the hallmarks of Alzheimer’s disease (AD) [4–7], with CSF biomarkers showing promise in the diagnostic workup of AD [8]. This evidence concerns the gene CP and Alzheimer disease.